OY MEDIX BIOCHEMICA AB has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets measurement, biotechnology and computer technology are JIANGSU FLON BIOTECHNOLOGY CO LTD, BEIJING STRONG BIOTECHNOLOGIES INC and SHENZHEN BLOT BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Finland | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Healthcare informatics | |
#3 | Enzymes | |
#4 | Peptides | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Sorsa Timo | 13 |
#2 | Korvuo Armi | 13 |
#3 | Tiisala Sinikka | 13 |
#4 | Salomaa Veikko | 7 |
#5 | Pussinen Pirkko | 7 |
#6 | Juhila Juuso | 7 |
#7 | Maier Kurt | 6 |
#8 | Gieselmann Dirk-Rolf | 5 |
#9 | Mäntylä Päivi | 4 |
#10 | Råman Ismo | 4 |
Publication | Filing date | Title |
---|---|---|
FI20165730A | Method for determining risks associated with cardiovascular diseases | |
FI127924B | Method of determining mmp-8 activation |